Skip to main content
Smart Investors Daily
RB

OTC · RBGLY

Reckitt Benckiser Group plc

Consumer Defensive · Household & Personal Products

$13.77

Up+$0.18 (+1.32%)

Updated Sep 11, 2026, 6:27 AM

SID Score

5.3/10

Composite research score

Smart Money

46/100

Neutral

Market cap
55.68B
P/E ratio
53.77
Dividend yield
3.94%
52-week range
— – —
Volume
85.71K
Avg. volume
292.67K

Price performance

RBGLY price history

1M range · 0 trading sessions · Daily adjusted prices

RBGLY does not have enough price history for the selected period.

Data unavailable

Market data is busy. Please try again shortly.

Latest RBGLY news

The latest Smart Investors Daily articles mentioning RBGLY.

RBGLY research

Overview

Company profile and research snapshot.

Company profile

RECKITT BENCKISR GP S/ADR

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
Hold
Average target
$17.08
Implied upside
Analysts
7
RBGLY recent ratings
DateFirmRatingTarget
Jun 16, 2026JefferiesHold
May 15, 2026RBC Capital MarketsNeutral
May 12, 2026JefferiesHold
Apr 28, 2026DeutscheHold
Apr 24, 2026Berenberg BankBuy
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Sep 1, 2026

Reckitt Gets a Baby Formula Break

Shares jumped after Mead Johnson won a key US trial, easing one of the biggest legal clouds hanging over the group.

Yahoo · Sep 1, 2026

Reckitt Benckiser shares rise over 4% as JP Morgan upgrades to 'overweight'

Shares in Reckitt Benckiser Group PLC (LSE:RKT, OTCQX:RBGLY), the consumer goods company behind Dettol and Nurofen, rose over 4% on Tuesday as investors digested a legal win for its Mead Johnson unit and a JP Morgan upgrade to overweight. The upgrade came in a wider note on European consumer...

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.